Hypoxic Culture of Human Pluripotent Stem Cell Lines is Permissible Using Mouse Embryonic Fibroblasts
Jennifer L. Badger(University of Bristol), Maeve A. Caldwell(University of Bristol), Ivan Wall(Aston University), Farlan Veraitch(Biochemical Society), Meg L. Byrne(University of Bristol), Chris Mason(Oak Ridge National Laboratory)
Cited by 9
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
|Regenerative Medicine|2011|144
Peak Serum: Implications of Serum Supply for Cell Therapy Manufacturing
|Regenerative Medicine|2011|144